Magnesiumnone

Minerals

Brand: Catie's

Tablet or PillMineralOff Market
Click to view full label

Net Contents

90 Tablet(s)

Serving Size

1–3 Tablet(s)

Servings Per Container

Not specified

Supplement Form

Tablet or Pill

Bar Code (UPC/SKU)

1 85707 00012 3

Product Version

Not Present

Label Analysis

Objective insights generated automatically from the official DSLD label — a quick, factual read of how this product is formulated and disclosed.

1Active Ingredients

Single-ingredient formula listed in Supplement Facts.

100%Amount Transparency

Every active ingredient discloses a specific amount per serving.

1% Daily Value Coverage

1 ingredients report an established %DV per serving.

2Dietary Attributes

Label states: Non-GMO, Gluten-Free.

This analysis is generated algorithmically from label data for educational reference only. It is not a product endorsement, ranking, or medical advice.

Supplement Facts

Serving Size: 1–3 Tablet(s) · 1 per day

IngredientAmount Per Serving% Daily Value
Magnesium50 mg12%
{Magnesium} FoodState1000 mg

Not Present

Other Ingredients

Vegetable LubricantSilicaGuar GumLecithinRutinFood Glaze

Target Groups

Adult (18 - 50 Years)Gluten FreeDairy Free

Label Claims

All Other

Directions & Suggested Use

Suggested/Recommended/Usage/Directions

FOR OPTIMAL DAILY NUTRITION: Take 1 to 3 tablets daily or as needed. Because it is food, it can be taken anytime with or without food.

Formulation

Formulation re: Does NOT Contain

This product does not contain any wheat, artificial sweeteners, sucrose, alcohol, MSG, yeast, gluten, salt, dairy, corn, egg, coloring, stabilizers, maltodextrins, any other artificial ingredients, or pesticides. NON-GMO.

Formula re: Contains

Additional Nutrients: Kelp & Dulce (Contains Trace Minerals)........... 20 mg Rice Bran .............................................. 145 mg

Other Label Statements

General Statements: All Other Content

Magnesium from whole food sources is essential for the many who have deficiencies.

General Statements: All Other Content

Marry blessings, health and happiness, Catie

General Statements: All Other Content

PROMOTES - Natural Calming Effect - Strong Bones - Easy Absorption - Good Circulation

Manufacturer & Distributor

Manufacturer

Energy Essentials(TM)

Other

(888) 456-1597

Where to Buy Locally

Enter your city or ZIP code to find supplement & health stores in your area that may carry this product.

Showing representative supplement & health retailers — search above for stores in your area.

Research & Studies

  • Extent of attaining and maintaining symptom remission by antipsychotic medication in the treatment of chronic schizophrenia: evidence from the CATIE study

    SZ Levine, J Rabinowitz, H Ascher-Svanum… - Schizophrenia …, 2011 - Elsevier

    … In CATIE, for methodological reasons, patients randomized prior to January 2002, who … CATIE allowed the use of off-label daily olanzapine doses of 22.5 or 30 mg. Doses of the other …

    201156 citations
  • CATIE News-Health agencies issue caution on saquinavir use

    SR Hosein - positivelypositive.ca

    … need to reduce the dose of saquinavir to 500 mg twice daily during the first week of use in … After the first week the dose of saquinavir is increased to the normal dose of 1,000 mg twice …

  • Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical …

    …, J Severe, JK Hsiao, Catie Investigators - American Journal of …, 2006 - psychiatryonline.org

    … Effectiveness (CATIE) investigation were randomly reassigned to double-blind treatment with a different antipsychotic (olanzapine, 7.5–30 mg/day [N=66]; quetiapine, 200–800 mg/day […

    2006608 citations
  • Population pharmacokinetic modeling of ziprasidone in patients with schizophrenia from the CATIE study

    AM Wessels, RR Bies, BG Pollock… - The Journal of Clinical …, 2011 - ovid.com

    … The CATIE study was initiated by the National Institute of Mental Health to determine the … olanzapine (7.5-30 mg), perphenazine (8-24 mg), quetiapine (200-800 mg), risperidone (1.5 …

    201127 citations
  • Effects of antipsychotic medications on psychosocial functioning in patients with chronic schizophrenia: findings from the NIMH CATIE study

    …, JA Lieberman, CATIE Investigators - American Journal of …, 2007 - psychiatryonline.org

    … Identical-appearing capsules contained olanzapine (7.5 mg), quetiapine (200 mg), risperidone (1.5 mg), perphenazine (8 mg) or, after January 2002, ziprasidone (40 mg). Patients with …

    2007424 citations
  • Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study

    GL Daumit, DC Goff, JM Meyer, VG Davis… - Schizophrenia …, 2008 - Elsevier

    … that the impact on 10-year CHD risk differs significantly between antipsychotic agents, with olanzapine producing the largest elevation in CHD risk of the agents studied in CATIE. …

    2008316 citations

Data sourced from the U.S. National Institutes of Health, Office of Dietary Supplements Dietary Supplement Label Database (DSLD) · Label entered 2013-06-25. DSLD Label ID: 22134. This information is provided for educational reference only and is not medical advice. Always follow the product label and consult a doctor or pharmacist before use.